The internal dosimetry user group position statement on molecular radiotherapy

8Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The Internal Dosimetry User Group (IDUG) is an independent, non-profit group of medical professionals dedicated to the promotion of dosimetry in molecular radiotherapy ( www. IDUG. org. uk). The Ionising Radiation (Medical Exposure) Regulations 2017, IR(ME)R, stipulate a requirement for optimisation and verification of molecular radiotherapy treatments, ensuring doses to non-target organs are as low as reasonably practicable. For many molecular radiotherapy treatments currently undertaken within the UK, this requirement is not being fully met. The growth of this field is such that we risk digressing further from IR(ME)R compliance potentially delivering suboptimal therapies that are not in the best interest of our patients. For this purpose, IDUG proposes ten points of action to aid in the successful implementation of this legislation. We urge stakeholders to support these proposals and ensure national provision is sufficient to meet the criteria necessary for compliance, and for the future advancement of molecular radiotherapy within the UK.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

GEAR, J., MCGOWAN, D., ROJAS, B., CRAIG, A. J., SMITH, A. L., SCOTT, C. J., … TIPPING, J. (2021, October 1). The internal dosimetry user group position statement on molecular radiotherapy. British Journal of Radiology. British Institute of Radiology. https://doi.org/10.1259/BJR.20210547

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

80%

Professor / Associate Prof. 1

20%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

43%

Physics and Astronomy 2

29%

Materials Science 1

14%

Computer Science 1

14%

Save time finding and organizing research with Mendeley

Sign up for free